HIGHLIGHTS
- who: Silvia Pomella and collaborators from the Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Via Montpellier, Rome, Italy have published the research work: DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma, in the Journal: (JOURNAL) of 23/01/2023
- what: The authors propose a DDR signature whose expression could be predictive of OSCC responsiveness to therapy. Evidence, in the current study, the authors have evaluated the alteration status and the expression of the DDR genes in a cohort of OSCC patients retrieved from The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.